- J - ANTIINFECTIVES FOR SYSTEMIC USE
- J05 - ANTIVIRALS FOR SYSTEMIC USE
- J05A - DIRECT ACTING ANTIVIRALS
- J05AR - Antivirals for treatment of HIV infections, combinations
- - Abacavir + lamivudine
- - Darunavir + cobicistat
- - Dolutegravir + abacavir + lamivudine
- - Dolutegravir + lamivudine
- - Dolutegravir + rilpivirine
- - Lamivudine + zidovudine
- - Lopinavir + ritonavir
- - bictegravir + emtricitabine + tenofovir alafenamide
- - darunavir + cobicistat + emtricitabine + tenofovir alafenamide
- - emtricitabine + rilpivirine + tenofovir alafenamide
- - emtricitabine + tenofovir alafenamide
- - tenofovir alafenamide + emtricitabine + elvitegravir + cobicistat
- - tenofovir disoproxil + emtricitabine
- - tenofovir disoproxil + emtricitabine + efavirenz
Last updated
1 June 2026
